secwatch.observer — SEC 8-K summary
======================================

Issuer:     GreenLight Biosciences Holdings, PBC (—)
CIK:        0001822691
Form:       8-K
Filed at:   2023-07-24T23:59:59+00:00
Accession:  0001193125-23-191971
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GreenLight completes going-private merger at $0.30/share; delisted from Nasdaq
------------------------------------------------------------------------------

- Merger consideration $0.30 per share in cash; aggregate ~$9.3M paid for non-rolled shares.
- Merger closed July 24, 2023; GreenLight becomes wholly owned subsidiary of SW ParentCo (Fall Line Capital-led).
- All prior directors resigned; Clay Mitchell appointed sole director, President, CFO, and Secretary.
- Fall Line Capital-led syndicate provided $52.075M in convertible secured notes ($15M previously advanced).
- Shares (GRNA) and warrants (GRNAW) ceased trading on Nasdaq effective July 24, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822691/000119312523191971/0001193125-23-191971-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822691/000119312523191971/d524112d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-191971

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer